Adolescent Health in Myanmar
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
Support Burnet’s Adolescent Health Programs in Myanmar today.
21 August, 2020
2019 was “yet another stellar year” for Burnet Institute, according to Burnet Chairman Ms Mary Padbury and Director and CEO, Professor Brendan Crabb AC in presenting the Annual Report.
Burnet Chairman, Ms Mary Padbury said the Institute is in a “very sound” financial position because of those grants, the strong performance of 360biolabs, and vital philanthropic support from the Institute’s network of donors.
“I would like to thank all those who so generously support the Institute and our work, especially at this challenging time,” Ms Padbury said.
Ms Padbury also highlighted the role the Institute has played in the global response to COVID-19 and praised the speed with which staff have pivoted to tackle the pandemic.
“I am very proud of the enormous contribution the Institute has made to the global, national and local response to the pandemic, as well as all our ongoing non-COVID-19 work,” Ms Padbury said.
Professor Crabb also praised the Institute’s role in the COVID-19 response, including the development of diagnostics, antivirals and vaccines, and Burnet staff have provided support and advice to health authorities and governments in Australia and abroad throughout the pandemic.
“Our staff have been called upon by the Australian and overseas (particularly Papua New Guinea) Governments to advise on the best approach to tackling the pandemic, and how we move through this and out the other side in the knowledge that it will be some time before we have a vaccine and therapeutic drugs,” Professor Crabb said.
Professor Crabb congratulated the Institute’s staff for reaching key public health and laboratory research milestones, and said he is looking forward to preparing for the next five years.
“While we may have met many of our objectives, 2020 brings the start of a new phase for the Institute as we commence planning for the medium to longer term, through the development of a new strategic plan to take us to 2025 and beyond,” he said.
Click to read more about Burnet’s activities and achievements in the 2019 Annual Report.
For more information in relation to this news article, please contact:
Director and CEO; Co-Head Malaria Research Laboratory; Chair, Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI)